<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Cambria;
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:Tahoma;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
        {font-family:Verdana;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0cm;
        margin-bottom:.0001pt;
        font-size:12.0pt;
        font-family:"Times New Roman","serif";}
h1
        {mso-style-priority:9;
        mso-style-link:"Heading 1 Char";
        mso-margin-top-alt:auto;
        margin-right:0cm;
        mso-margin-bottom-alt:auto;
        margin-left:0cm;
        font-size:24.0pt;
        font-family:"Times New Roman","serif";
        font-weight:bold;}
h5
        {mso-style-priority:9;
        mso-style-link:"Heading 5 Char";
        mso-margin-top-alt:auto;
        margin-right:0cm;
        mso-margin-bottom-alt:auto;
        margin-left:0cm;
        font-size:10.0pt;
        font-family:"Times New Roman","serif";
        font-weight:bold;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
p
        {mso-style-priority:99;
        mso-margin-top-alt:auto;
        margin-right:0cm;
        mso-margin-bottom-alt:auto;
        margin-left:0cm;
        font-size:12.0pt;
        font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
        {mso-style-priority:99;
        mso-style-link:"Balloon Text Char";
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:8.0pt;
        font-family:"Tahoma","sans-serif";}
span.Heading5Char
        {mso-style-name:"Heading 5 Char";
        mso-style-priority:9;
        mso-style-link:"Heading 5";
        font-family:"Cambria","serif";
        color:#243F60;}
span.messagebody
        {mso-style-name:messagebody;}
span.usercontent
        {mso-style-name:usercontent;}
span.textexposedshow
        {mso-style-name:text_exposed_show;}
span.wordbreak
        {mso-style-name:word_break;}
span.yui320211337705726574117
        {mso-style-name:yui_3_2_0_21_1337705726574117;}
span.Heading1Char
        {mso-style-name:"Heading 1 Char";
        mso-style-priority:9;
        mso-style-link:"Heading 1";
        font-family:"Cambria","serif";
        color:#365F91;
        font-weight:bold;}
p.yiv130114537msoacetate, li.yiv130114537msoacetate, div.yiv130114537msoacetate
        {mso-style-name:yiv130114537msoacetate;
        mso-margin-top-alt:auto;
        margin-right:0cm;
        mso-margin-bottom-alt:auto;
        margin-left:0cm;
        font-size:12.0pt;
        font-family:"Times New Roman","serif";}
p.yiv130114537msonormal, li.yiv130114537msonormal, div.yiv130114537msonormal
        {mso-style-name:yiv130114537msonormal;
        mso-margin-top-alt:auto;
        margin-right:0cm;
        mso-margin-bottom-alt:auto;
        margin-left:0cm;
        font-size:12.0pt;
        font-family:"Times New Roman","serif";}
span.yiv130114537msohyperlink
        {mso-style-name:yiv130114537msohyperlink;}
span.yiv130114537msohyperlinkfollowed
        {mso-style-name:yiv130114537msohyperlinkfollowed;}
span.yiv130114537heading1char
        {mso-style-name:yiv130114537heading1char;}
span.yiv130114537balloontextchar
        {mso-style-name:yiv130114537balloontextchar;}
span.yiv130114537emailstyle23
        {mso-style-name:yiv130114537emailstyle23;}
p.yiv130114537msonormal1, li.yiv130114537msonormal1, div.yiv130114537msonormal1
        {mso-style-name:yiv130114537msonormal1;
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:12.0pt;
        font-family:"Times New Roman","serif";}
span.yiv130114537msohyperlink1
        {mso-style-name:yiv130114537msohyperlink1;
        color:blue;
        text-decoration:underline;}
span.yiv130114537msohyperlinkfollowed1
        {mso-style-name:yiv130114537msohyperlinkfollowed1;
        color:purple;
        text-decoration:underline;}
p.yiv130114537msoacetate1, li.yiv130114537msoacetate1, div.yiv130114537msoacetate1
        {mso-style-name:yiv130114537msoacetate1;
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:8.0pt;
        font-family:"Tahoma","sans-serif";}
span.yiv130114537heading1char1
        {mso-style-name:yiv130114537heading1char1;
        font-family:"Cambria","serif";
        color:#365F91;
        font-weight:bold;}
span.yiv130114537balloontextchar1
        {mso-style-name:yiv130114537balloontextchar1;
        font-family:"Tahoma","sans-serif";}
span.yiv130114537emailstyle231
        {mso-style-name:yiv130114537emailstyle231;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.yiv130114537date
        {mso-style-name:yiv130114537date;}
span.BalloonTextChar
        {mso-style-name:"Balloon Text Char";
        mso-style-priority:99;
        mso-style-link:"Balloon Text";
        font-family:"Tahoma","sans-serif";}
span.EmailStyle42
        {mso-style-type:personal-reply;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-size:10.0pt;}
@page WordSection1
        {size:612.0pt 792.0pt;
        margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
        {page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Below is the meeting announcement for the PCCN Brampton Prostate Support Group meeting for Tuesday 8 Jan 13.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>This is an opportunity to attend a neighbouring PCCN chapter Support Group Meeting and hear a firsthand story of a man’s PCa journey.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Take care,<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Glen Tolhurst <o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Chair – PCCN Waterloo-Wellington<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><div><h5 style='background:white'><span class=usercontent><span style='font-family:"Verdana","sans-serif";color:black'>You are cordially invited to attend Prostate Cancer Canada Network - Brampton's Next General Meeting on Tuesday, Jan. 8th, 2013 – 7:00pm</span></span><span style='font-family:"Verdana","sans-serif";color:black'><br><span class=usercontent>Percy Bedard and his caregiver Heather Redick will tell us about Percy’s journey from apparent good health to his shocking diagnosis with Stage 4 Prostate Cancer through two years of treatment and a successful battle to have the drug called Zytiga approved for payment by OHIP.</span><br><br><span class=usercontent>You may remember that Team Percy appeared at Cruisin' for a Cure on September 9th, 2012 and obtained about 1,000 signatures on their petition to the Ministry of Health.</span><br><span class=usercontent>Percy has been on Zytiga since November and the results have been nothing short of spectacular as Heather recently reported: </span><br><span class=textexposedshow><i>I can tell you that the drug (first hand knowledge) is unbelievable. Percy has had no side effects....no waits in the chemo room.....no pain....just a continued feeling of well being. It is almost criminal to think that men had to wait 15 months.... suffer for 15 months....some died in the 15 months....while Ontario, oblivious to pain and suffering, put off/ignored/failed/disregarded funding approval. Lesson to all: Fight for what you believe in and don't accept Government ignorance and indecision! Make them listen! Make noise! Make them accountable!</i></span><br><br><span class=textexposedshow>Theirs is a unique, inspiring story that shows what ordinary people can accomplish when they decide to take on an indifferent bureaucracy. Please don’t miss this opportunity to meet Percy and Heather!</span><br><br><span class=textexposedshow><span style='background:yellow;mso-highlight:yellow'>We look forward to seeing you in Room #2, upstairs at </span></span><span style='background:yellow;mso-highlight:yellow'><br><span class=textexposedshow>The Terry Miller Recreation Center, 1295 Williams Parkway, </span><br><span class=textexposedshow>at the southwest corner of Williams Parkway & Bramalea Road.</span></span><span class=textexposedshow> </span><br><br><span class=textexposedshow>Admission and parking are free. Refreshments will be served.</span><br><span class=textexposedshow>Please forward your questions or suggestions to: <a href="mailto:jfdorsey@yahoo.com">jfdorsey@yahoo.com</a></span><o:p></o:p></span></h5></div></div></body></html>